The NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS)
Forecast
National Institutes of Health plans to offer grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It is a forecast: the notice is expected around September 1, 2026, with applications due around November 1, 2026.
From the official notice on Grants.gov, last changed May 18, 2026. Checked October 31, 2026.
- Award ceilingnot stated
- Award floornot stated
- Expected awardsnot stated
- Total fundingnot stated
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Forecast posted | May 18, 2026 |
|---|---|
| Expected posting | September 1, 2026 |
| Expected deadline | November 1, 2026 |
| Expected award date | July 31, 2027 |
Add the deadline to your calendar
Who can apply
This opportunity is open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The National Institute on Aging (NIA) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications to develop, operate, and sustain a cloud-based data storage and computing platform that democratizes access to large-scale Alzheimer’s disease (AD) and AD-related dementias (ADRD) genetic and genomic data. The platform must be secure, scalable, and interoperable. The platform will support the NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS), the primary NIA-supported repository for the archiving and distribution of human genetic data related to AD/ADRD. The purpose of the platform will be to: Enable efficient ingestion, curation, harmonization, and analysis of multi-ancestry, large population-scale datasets; Provide robust analysis, visualization, and artificial intelligence -ready resources within secure cloud workspaces; Ensure compliance with federal security and data-sharing policies; Promote interoperability with other NIH- and NIA-supported repositories; and Provide user support, training, and community engagement. The NOFO aims to foster collaboration, accelerate discovery, and maximize the scientific value and impact of AD/ADRD genetics research for the broader research community. By improving data accessibility, interoperability, reporting, reproducibility, and scalable computational systems that enable rigorous, reproducible, and transparent research, the NOFO seeks to align with the NIH’s plan for Gold Standard Science and the AD/ADRD Research Implementation Milestones. Additionally, the NOFO seeks to address the Academies of Sciences, Engineering, and Medicine's recommendation of ensuring broad, secure access to high-value datasets and enhancing data usability to maximize the return on research investments and support future discoveries in AD/ADRD. Moreover, the NOFO intends to directly advance NIA’s Strategic Directions, particularly Goal G to support the infrastructure and resources necessary for high-quality research, by strengthening data sharing, computational infrastructure, and research rigor across the AD/ADRD community. The NOFO intends to utilize the U24 activity code. Applications are not being solicited at this time. This notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to NIA Scientific Contact, NIA-NOFO-Scientific@nih.gov, Please contact via e-mail..
Questions people ask
Who can apply for The NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS)?
National Institutes of Health accepts applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for The NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS)?
Expected deadline November 1, 2026. Confirm the date and time in the official notice on Grants.gov.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience